Showing results (641-650 of 1,177) with videos related to
Sort By:
Pageof 118
Applied Health Economics and Health Policy|April 1, 2025
Alternative Payment Models for Innovative Medicines: A Framework for Effective ImplementationFrederick McElwee, Amanda Cole, Gomathi Kaliappan, et al.Applied Health Economics and Health Policy|June 17, 2025
Discrete Event Simulation in R using the 'Simmer' Package for Health Economic Modelling: A Tutorial and Illustration in Colon CancerKoen Degeling, Jonathan Karnon, Michiel van de Ven, et al.Applied Health Economics and Health Policy|February 17, 2026
Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer ScreeningMax Lelie, Bo VandenBulcke, Nick Verhaeghe, et al.Applied Health Economics and Health Policy|January 30, 2026
Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them?Rachel J Oidtman, Min Huang, Walter A Orenstein, et al.Applied Health Economics and Health Policy|May 7, 2013
New anti-rebate legislation in South KoreaSu-Yeon Yu, Bong-Min Yang, Jin-Hyun KimApplied Health Economics and Health Policy|May 8, 2013
Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndromeStefan Kaspers, Michael B Ranke, Donald Han, et al.Applied Health Economics and Health Policy|April 13, 2013
Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspectiveVijay N Joish, Monica Spilsbury-Cantalupo, Elisabeth Operschall, et al.Applied Health Economics and Health Policy|March 16, 2013
The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluationsEvanthia Achilla, Paul McCroneApplied Health Economics and Health Policy|May 17, 2013
Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costsJuliana Meyers, Yanni Yu, James A Kaye, et al.Applied Health Economics and Health Policy|July 13, 2013
Systematic review of drug administration costs and implications for biopharmaceutical manufacturingEbenezer Tetteh, Stephen MorrisPageof 118